Research Explorer

Project

Innovative MulticOmponent Drug dEsign (MODE) for enhancing regional strategic advantages in pharmaceutical and biomedical applications
Acronym
IMODE
Code
41Q07816
Duration
01 July 2016 → 30 June 2021
Funding
European funding: various
Research disciplines
  • Medical and health sciences
    • Pharmaceutical technology
Keywords
Drug development
Other information
 
Project description
 

The overall objective is to enhance R&D on major societal challenges for improved healthcare by developing solutions for novel pharmaceutical products and

medical devices through new multicomponent drug systems. Our strategy will involve major stakeholders in the field including Universities, small and large

entreprises and final users (patients) as well as an economic development agency. Technology transfer and industrial competitiveness will be enhanced. Trainings

through technological develop. will create highly skilled scientists reducing the shortage of qualified staff in the field.

 
 
 
Disclaimer
Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Regional Development Fund, ERDF. Neither the European Union nor the authority can be held responsible for any use the may be made of the information contained therein.